Preventing the unthinkable from becoming the inevitable
The Ineos Oxford Institute for Antimicrobial Research was established to rapidly advance the search for solutions to one of the biggest public health challenges of our time. We work in the lab, in the field and with the public to discover new ways to prevent and treat drug resistant infections.
Oxford University played a crucial role in the early development of antibiotics 80 years ago. It's time to usher in a new era of antibiotic discovery to combat the growing threat of antimicrobial resistance.
Most antibiotics used to treat bacterial infections in humans are also used in animals, which is a major contributory factor to the growth of AMR. We are designing novel screening programmes and new candidate compounds to discover viable alternative antibiotics that can be used solely in agriculture and aquaculture, and produce zero cross-resistance to human antibiotics.
Animal-only antibiotics
We apply state of the art pre-clinical medicinal chemistry to antibacterial drug discovery to enable and promote the development of breakthrough new treatments for human bacterial infections. Our science-focused approach is interdisciplinary and highly collaborative, both within Oxford and internationally.
New human antibiotics
We undertake international, collaborative studies with global surveillance and assessment programmes to understand the impact of antibiotic resistance on low and middle income countries. We aim to develop important actionable estimates of the AMR burden that will impact global and regional policy decisions.
The breadth and scale of the AMR threat calls for extraordinary, proactive collaboration and communication.
A brand new interdisciplinary research institute at Oxford
We were founded at the University of Oxford in January 2021. This website provides a brief overview of who we are, what we do and how we work. As we become more established, develop findings and undertake activities to inform and influence action against AMR, we will grow our digital presence to provide more opportunities to learn and engage with wider audiences.
